STOCK TITAN

Ryvyl Financials

RVYL
FY2025 annual
Revenue $11.1M -38.7% YoY
Net Income -$17.5M +34.7% YoY
EPS (Diluted) -$29.33 YoY not available
Free Cash Flow -$23.1M -209.3% YoY
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

Ryvyl (RVYL) reported $11.1M in revenue for fiscal year 2025, down 38.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RVYL FY2025

Ryvyl’s dominant mechanic is volatile cash conversion: gross-profit improvement has not translated into operating self-funding.

Operating cash flow was positive at $33.2M in FY2023 and $21.2M in FY2024 despite reported losses, indicating that accounting losses were being offset by noncash or balance-sheet effects. That support reversed in FY2025, when operating cash flow reached -$23.0M, making the loss more cash-intensive.

Revenue fell to $11.1M in FY2025 from $18.2M in FY2024, yet gross margin expanded by 7.0 percentage points. Margin improvement did not reach operating profit: operating margin remained deeply negative at -118.1%, so gross-profit gains still failed to cover the operating structure.

Cash stood at $7.4M against current liabilities of $10.0M, leaving immediate obligations larger than cash reserves. Low capital intensity—capital expenditures were only $79K—contrasted with free cash flow of -$23.1M, while financing provided $13.9M; the financing mix, rather than reinvestment spending, explains the near-term cash support.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 31 / 100
Financial Health Score 31/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Ryvyl's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
19
Dilution
88
R&D Intensity
14
Revenue Progress
3
Burn Trend
0

Not available for Ryvyl, and counted as zero in the overall score.

Balance Sheet
63
Altman Z-Score Distress
-22.92

Ryvyl scores -22.92, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($10.0M) relative to total liabilities ($12.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Ryvyl passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Ryvyl reported a net loss of $17.5M while operations used $23.0M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Ryvyl reported an operating loss of $13.1M against $1.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$11.1M
YoY-38.7%
5Y CAGR+5.5%

Ryvyl generated $11.1M in revenue in fiscal year 2025. This represents a decrease of 38.7% from the prior year.

EBITDA
-$12.7M
YoY+49.3%

Ryvyl's EBITDA was -$12.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 49.3% from the prior year.

Net Income
-$17.5M
YoY+34.7%

Ryvyl reported -$17.5M in net income in fiscal year 2025. This represents an increase of 34.7% from the prior year.

EPS (Diluted)
-$29.33

Ryvyl earned -$29.33 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$23.1M
YoY-209.3%

Ryvyl recorded an outflow of $23.1M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 209.3% from the prior year.

Cash & Debt
$7.4M
YoY+185.7%
10Y CAGR+66.0%

Ryvyl held $7.4M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
1M

Ryvyl had 1M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
47.7%
YoY+7.0pp
5Y CAGR+4.3pp

Ryvyl's gross margin was 47.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 7.0 percentage points from the prior year.

Return on Equity
-2623.7%

Ryvyl's ROE was -2623.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$559K
YoY-85.5%
5Y CAGR-16.3%

Ryvyl invested $559K in research and development in fiscal year 2025. This represents a decrease of 85.5% from the prior year.

Capital Expenditures
$79K
YoY+68.1%
5Y CAGR+64.0%
10Y CAGR+11.1%

Ryvyl invested $79K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 68.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

RVYL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVYL annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$10.9M$11.1M-38.7%$18.2M-72.4%$65.9M+100.2%$32.9M+25.1%$26.3M+208.6%$8.5M-14.8%$10.0M+998.2%$911K+111.3%$431KN/A$2.1MN/A$1.7M+249.1%$493K-12.6%$564K
Cost of Revenue$5.8M$5.8M-45.9%$10.8M-73.2%$40.2M+139.2%$16.8M+66.7%$10.1M+108.7%$4.8M-56.5%$11.1M+1554.1%$671K$0N/A$1.2MN/A$654KN/AN/A
Gross Profit$5.1M$5.3M-28.2%$7.4M-71.2%$25.7M+59.5%$16.1M-0.7%$16.2M+338.8%$3.7M+439.9%-$1.1M-552.9%$240K$0N/A$962KN/A$1.1M+361.9%$231KN/A
R&D Expenses$186K$559K-85.5%$3.8M-33.2%$5.8M-8.3%$6.3M+62.2%$3.9M+183.8%$1.4M+8.6%$1.3M+438814.7%$286-99.4%$46KN/AN/AN/AN/AN/AN/A
SG&A Expenses$4.0M$4.4M+47.8%$3.0M-65.7%$8.7M+31.4%$6.6M-60.9%$16.9M+2009.5%$800K+6.7%$750K+148.1%$302K+3165.3%$9KN/A$608KN/A$452K+495.6%$76K-37.4%$121K
Operating Income-$11.8M-$13.1M+51.7%-$27.2M-121.2%-$12.3M+67.5%-$37.8M-29.6%-$29.2M-472.2%-$5.1M+9.0%-$5.6M-227.9%-$1.7M-1130.3%-$139K-222.6%$113K-67.9%$353K-20.2%$443K-28.0%$615K+296.4%$155K-42.9%$271K
Interest Expense-$2.9M-$1.8M-106.3%-$869K+74.0%-$3.3M-122.1%$15.1M+404.4%$3.0M+160.4%$1.1M+489.0%$195K+549.2%$30K$0-100.0%$22K+4.2%$21K-27.2%$29K-58.6%$70K-29.8%$100K-1.8%$102K
Income Tax$181K$318K-18.5%$390K+34.9%$289K+3712.5%-$8K-263.1%$5K$0$0$0$0-100.0%$37K-48.4%$72K-54.8%$159K$0$0N/A
Net Income-$18.1M-$17.5M+34.7%-$26.8M+49.5%-$53.1M-7.8%-$49.2M-39.6%-$35.3M-604.5%-$5.0M-6.9%-$4.7M-147.4%-$1.9M-1259.0%-$139K-340.8%$58K-77.8%$260K+616.4%$36K-93.3%$544K+893.6%$55K-67.2%$167K
EPS (Diluted)-$29.33-$140.25-$10.11N/AN/AN/AN/AN/A$0.01$0.00-100.0%$0.02$0.00-100.0%$0.02$0.01N/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

RVYL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVYL annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$13.1M-89.3%$122.3M-5.0%$128.7M+31.8%$97.7M-14.4%$114.0M+830.0%$12.3M-0.9%$12.4M+1097.3%$1.0M+1014.3%$93K-24.6%$123K-42.5%$214K+133.3%$92K-61.5%$238K+284.7%$62K-65.9%$182K
Current Assets$11.1M-88.3%$95.4M+6.1%$89.9M+51.8%$59.2M-38.7%$96.6M+704.3%$12.0M-0.6%$12.1M+1104.4%$1.0M+1056.9%$87K+39.0%$62K-62.0%$164K+167.6%$61K-71.7%$216K+249.7%$62K-65.9%$182K
Cash & Equivalents$7.4M+185.7%$2.6M-78.7%$12.2M-12.8%$14.0M-84.3%$89.0M$0$0-100.0%$46K-45.0%$83K$0-100.0%$47K+12.7%$41K-79.9%$206K+2253.4%$9K+65.8%$5K
InventoryN/AN/AN/A$302K+5.5%$286K$0N/AN/AN/AN/AN/AN/AN/AN/AN/A
Accounts Receivable$1.1M+3.5%$1.1M+25.3%$859K-25.7%$1.2M+140.0%$482K+4716.7%$10K-85.8%$70K+40.5%$50K$0$0N/AN/AN/AN/AN/A
Goodwill$0-100.0%$18.9M0.0%$18.9M-29.5%$26.8M+308.6%$6.5M$0N/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$12.4M-90.0%$123.8M+17.7%$105.2M+5.6%$99.6M+17.7%$84.6M+466.3%$14.9M-15.8%$17.7M+808.5%$2.0M+6006.6%$32K-95.7%$737K-16.8%$886K-13.5%$1.0M-15.1%$1.2M-33.1%$1.8M-8.8%$2.0M
Current Liabilities$10.0M-90.3%$103.5M+21.0%$85.5M+132.9%$36.7M+51.6%$24.2M+106.7%$11.7M-33.5%$17.6M+838.4%$1.9M+5772.1%$32K-95.6%$722K+31.0%$551K-8.5%$602K+17.4%$513K+150.1%$205K+101.6%$102K
Long-Term DebtN/A$17.4M+9.1%$15.9M-74.2%$61.7M+4.1%$59.3M+39463.1%$150K$0-100.0%$75K$0-100.0%$2K-66.7%$7K-37.9%$12K-31.0%$17K$0N/A
Total Equity$668K+144.8%-$1.5M-106.4%$23.5M+1321.6%-$1.9M-106.5%$29.5M+1202.9%-$2.7M+50.2%-$5.4M-483.9%-$919K-1612.4%$61K+109.9%-$614K+8.6%-$672K+27.9%-$932K+3.8%-$969K+44.4%-$1.7M+3.0%-$1.8M
Retained Earnings-$196.9M-9.8%-$179.4M-17.6%-$152.6M-52.9%-$99.8M-97.4%-$50.5M-331.0%-$11.7M-74.5%-$6.7M-230.5%-$2.0M-1359.0%-$139K-150.9%$274K+26.8%$216K+587.1%-$44K+45.0%-$81K+87.1%-$625K+65.4%-$1.8M

RVYL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RVYL annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow-$9.5M-$23.0M-208.7%$21.2M-36.1%$33.2M+454.9%-$9.3M+59.4%-$23.0M-453.0%-$4.2M-2554.4%-$157K+90.2%-$1.6M-1350.0%-$110K-469.2%$30K-88.6%$262K-21.7%$334K-47.4%$636K+91.7%$332K+262.1%-$205K
Capital Expenditures$71K$79K+68.1%$47K-56.5%$108K-33.3%$162K+2.0%$159K+2289.2%$7K-86.6%$50K+59.3%$31K+397.8%$6K+71.8%$4K-86.7%$28K+85.5%$15K$0N/AN/A
Free Cash Flow-$9.6M-$23.1M-209.3%$21.1M-36.0%$33.1M+447.7%-$9.5M+59.0%-$23.2M-455.9%-$4.2M-1917.7%-$207K+87.4%-$1.6M-1298.8%-$117K-544.5%$26K-88.8%$234K-26.7%$319K-49.7%$636KN/AN/A
Investing Cash Flow-$75.1MN/A-$1.8M-179.1%$2.3M+104.9%-$46.4M-1645.4%-$2.7M-39888.8%-$7K+86.6%-$50K-59.3%-$31K-397.8%-$6K-71.8%-$4K+97.1%-$125K-396.4%-$25K-158.9%$43K$0$0
Financing Cash Flow$12.3M$13.9M+5863.1%-$241K+92.0%-$3.0M+70.1%-$10.0M-109.0%$111.9M+2036.8%$5.2M+664.9%$685K-62.7%$1.8M+816.9%$200K+598.1%-$40K+69.4%-$131KN/A-$481K-46.6%-$328K-264.2%$200K
Share BuybacksN/AN/AN/AN/A$0$0$0N/AN/AN/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

RVYL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

RVYL annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin47.7%+7.0pp40.7%+1.7pp39.0%-9.9pp49.0%-12.7pp61.7%+18.3pp43.4%+54.3pp-10.9%-37.3pp26.4%+26.4pp0.0%N/A45.4%N/A62.0%+15.1pp46.9%N/A
Operating Margin-118.1%-149.9%-18.7%-115.0%-111.0%-59.9%-3.8pp-56.1%-187.9%-32.3%N/A16.7%N/A35.7%+4.3pp31.5%-16.7pp48.1%
Net Margin-157.4%-147.7%-80.6%-149.6%-134.1%-58.7%-11.9pp-46.8%-207.9%-32.3%N/A12.3%N/A31.6%+20.5pp11.1%-18.5pp29.6%
Return on Equity-2623.7%N/A-226.0%N/A-119.7%N/AN/AN/A-229.2%N/AN/AN/AN/AN/AN/A
Return on Assets-133.8%-111.8pp-21.9%+19.3pp-41.3%+9.1pp-50.4%-19.5pp-30.9%+9.9pp-40.8%-3.0pp-37.9%+145.3pp-183.2%-33.0pp-150.2%-197.2pp47.0%-74.8pp121.8%+82.1pp39.6%-189.1pp228.8%+140.2pp88.6%-3.4pp92.0%
Current Ratio1.11+0.2x0.92-0.1x1.05-0.6x1.61-2.4x3.98+3.0x1.02+0.3x0.69+0.2x0.53-2.2x2.71+2.6x0.09-0.2x0.30+0.2x0.10-0.3x0.42+0.1x0.30-1.5x1.79
Debt-to-Equity18.61N/A0.68N/A2.01N/AN/AN/A0.00N/AN/AN/AN/AN/AN/A
FCF Margin-207.7%116.4%50.2%+79.1pp-28.9%+59.2pp-88.1%-39.2pp-48.9%-46.8pp-2.1%-179.3%-27.1%N/A11.0%N/A36.9%N/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Ryvyl's annual revenue?

Ryvyl (RVYL) reported $11.1M in total revenue for fiscal year 2025. This represents a -38.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ryvyl's revenue growing?

Ryvyl (RVYL) revenue declined by 38.7% year-over-year, from $18.2M to $11.1M in fiscal year 2025.

Is Ryvyl profitable?

No, Ryvyl (RVYL) reported a net income of -$17.5M in fiscal year 2025.

Ryvyl (RVYL) reported diluted earnings per share of -$29.33 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ryvyl (RVYL) had EBITDA of -$12.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Ryvyl (RVYL) had a gross margin of 47.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Ryvyl (RVYL) has a return on equity of -2623.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Ryvyl (RVYL) recorded an outflow of $23.1M in free cash flow during fiscal year 2025. This represents a -209.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Ryvyl (RVYL) recorded an outflow of $23.0M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Ryvyl (RVYL) had $13.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Ryvyl (RVYL) invested $79K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Ryvyl (RVYL) invested $559K in research and development during fiscal year 2025.

Ryvyl (RVYL) had 1M shares outstanding as of fiscal year 2025.

Ryvyl (RVYL) had a current ratio of 1.11 as of fiscal year 2025, which is considered adequate.

Ryvyl (RVYL) had a debt-to-equity ratio of 18.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Ryvyl (RVYL) had a return on assets of -133.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Ryvyl (RVYL) had $7.4M in cash against an annual operating cash burn of $23.0M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Ryvyl (RVYL) has an Altman Z-Score of -22.92, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Ryvyl (RVYL) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Ryvyl (RVYL) reported a net loss of $17.5M while operations used $23.0M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Ryvyl (RVYL) reported an operating loss of $13.1M against $1.8M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Ryvyl (RVYL) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top